Authors:
GENEVOIS E
LELOUER V
VERCKEN JB
CAILLON R
Citation: E. Genevois et al., STUDY DESIGN, METHODOLOGY AND STATISTICAL-ANALYSES IN THE CLINICAL DEVELOPMENT OF SPARFLOXACIN, Journal of antimicrobial chemotherapy, 37, 1996, pp. 65-72
Authors:
RAVDIN PM
BURRIS HA
COOK G
EISENBERG P
KANE M
BIERMAN WA
MORTIMER J
GENEVOIS E
BELLET RE
Citation: Pm. Ravdin et al., PHASE-II TRIAL OF DOCETAXEL IN ADVANCED ANTHRACYCLINE-RESISTANT OR ANTHRACENEDIONE-RESISTANT BREAST-CANCER, Journal of clinical oncology, 13(12), 1995, pp. 2879-2885
Authors:
SPIRO TE
STEPHENS JWG
GENEVOIS E
HAAS J
DOBBINS T
Citation: Te. Spiro et al., EXPLORATORY ANALYSIS OF THE RELATIONSHIP BETWEEN OBESITY AND OTHER RISK-FACTORS AND PRIMARY EFFICACY AND SAFETY OUTCOMES IN ENOXAPARIN STUDIES OF VENOUS THROMBOEMBOLIC DISEASE PREVENTION AFTER TOTAL HIP AND KNEE REPLACEMENT, Blood, 86(10), 1995, pp. 3691-3691